Article
A unified model for staging amyloid and tau pathology in Alzheimer’s disease
2026-03-31
Abstract excerpt
Biological staging models are a key tool for assessing the severity of Alzheimer’s disease (AD), supporting personalized medicine and playing a critical role in clinical trial design. Recently, researchers have leveraged positron emission tomography (PET) to inform data-driven staging models of brain pathology related to AD. However, most approaches have focused on staging either amyloid or tau progressions separa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 706d814a-8076-5ec7-bbdd-ff9561d9107e
- DOI
- 10.64898/2026.03.30.26349752
